Clinical Trials

Phase 1/2 Not yet recruiting

Non-Muscle Invasive Bladder Urothelial Carcinoma

NCT07217990 2026-02-17

NoCUT-BC

84 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07365306 2026-01-26

Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

43 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT07323641 2026-01-07

Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer

60 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07293403 2025-12-19

Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas

Phase 1 Not yet recruiting

25 enrolled

Lymphoid

Lymphoma, T-Cell

NCT07145177 2025-12-18

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

30 enrolled

Prostatic Neoplasms

NCT06492759 2025-12-16

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

Phase 3 Not yet recruiting

29 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07271355 2025-12-09

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

129 enrolled

Appendiceal Neoplasms, Colorectal Neoplasms

NCT07226544 2025-11-10

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

31 enrolled

Carcinoma, Renal Cell

NCT07218692 2025-10-20

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

35 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT07089940 2025-07-29

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

12 enrolled

Pancreatic Neoplasms

NCT07080333 2025-07-23

MICROBLADDERK

95 enrolled

Tumor-Agnostic

Neoplasms

NCT06782048 2025-01-17

Use of Pyrvinium to Reverse Stomach Precancerous Conditions

50 enrolled

Stomach Neoplasms

NCT06528223 2024-07-30

Research of the Application of Artificial Intelligence Model "PANDA"

200,000 enrolled

Pancreatic Neoplasms

NCT06438939 2024-06-03

NBI_Oral

480 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT06418516 2024-05-17

ANGELA

GastrointestinalHead & Neck

340 enrolled

Carcinoma, Squamous Cell, Esophageal Neoplasms, Head and Neck Neoplasms

NCT06366516 2024-04-16

MTTRIHPW